Nanoviricides (NNVC) Capital Expenditures (2010 - 2026)
Nanoviricides' Capital Expenditures came in at $1.00 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 100.0% from $10,200 a year earlier.
Powered by 
Analysis
Nanoviricides (NNVC) Capital Expenditures (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides' Capital Expenditures was $84,317, up 48.0% from FY2025.
- Capital Expenditures carries a five-year compound annual growth rate of -18.8% (FY2021 to FY2026).
- Going back by fiscal year, Capital Expenditures was $56,964 in FY2025 (-63.6%), $156,560 in FY2024 (+3.2%), $151,712 in FY2023 (-53.2%) and $324,348 in FY2022 (+35.8%).
- The five-year range for quarterly Capital Expenditures is -$1.00 (fiscal Q2 2026) to $185,350 (fiscal Q2 2022).
- Year-over-year, Capital Expenditures increased in two of the last four quarters, with growth averaging 88.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q1 2025 (growth of 464.0%), and the weakest in fiscal Q4 2026 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Nanoviricides | 28.47 Mn | 16.13 Mn | - | 1.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 |
| Dec 31, 2025 | -1.00 |
| Sep 30, 2025 | 84,317.00 |
| Jun 30, 2025 | 10,200.00 |
| Sep 30, 2024 | 46,764.00 |
| Jun 30, 2024 | 98,163.00 |
| Mar 31, 2024 | 44,632.00 |
| Dec 31, 2023 | 5,474.00 |
| Sep 30, 2023 | 8,291.00 |
| Jun 30, 2023 | 2,566.00 |
| Mar 31, 2023 | 59,301.00 |
| Dec 31, 2022 | 45,339.00 |
| Sep 30, 2022 | 44,506.00 |
| Jun 30, 2022 | 75,362.00 |
| Mar 31, 2022 | 39,323.00 |
| Dec 31, 2021 | 185,350.00 |
| Sep 30, 2021 | 24,313.00 |
| Jun 30, 2021 | 84,643.00 |
| Mar 31, 2021 | 110,557.00 |
| Dec 31, 2020 | 8,580.00 |
API Access
Nanoviricides Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NNVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();